Dr. Preeti A. Reshamwala

Stephen Pastan is a Transplant Surgeon practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 45 years. Dr. Pastan is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Glomerulonephritis, Kidney Transplant, and Colonoscopy. Dr. Pastan is board certified in American Board Of Internal Medicine, 1991.

Dr. Marti received her undergraduate degree in 2002 from The University of Georgia in Athens and earned her medical degree in 2007 from Mercer University where she was elected to the Alpha Omega Alpha honor society. She completed her Internal Medicine residency and General Cardiology fellowship at Emory University in Atlanta. Dr. Marti completed an additional year in Advanced Heart Failure and Transplant Cardiology and also received her Masters in Clinical Research during her training at Emory.Dr. Marti is board certified in Internal Medicine, General Cardiology, Echocardiography and Advanced Heart Failure and Transplant Cardiology. She is a member of the American College of Cardiology, American Heart Association, Heart Failure Society of America and International Society of Heart and Lung Transplantation. She has received grant funding from the American Heart Association and remains involved with heart failure research with many active clinical trials and journal publications. Her clinical interests include heart failure and transplant cardiology, mechanical circulatory support, congenital heart disease, cardio-oncology, cardiac imaging and women's heart disease, including heart disease during pregnancy.In her spare time, Dr. Marti enjoys spending time with her family, traveling and playing tennis. Dr. Marti welcomes new patients and accepts most insurance plans. Dr. Marti is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Heart Failure, Cardiomyopathy, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), and Heart Transplant. Dr. Marti is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine - Cardiovascular Disease. Dr. Marti is currently accepting new patients.

Dr. Lance Stein is transplant hepatologist and the Medical Director of Piedmont's Hepatology and Liver Transplant Program since 2021. He has been at Piedmont since 2010. He is a Clinical Assistant Professor of Medicine at Mercer University School of Medicine. His special interests include viral hepatitis, alcohol related liver disease, acute on chronic liver failure, metabolic associated steatotic liver disease (MASH/MAFLD), and autoimmune liver diseases (including but not limited to autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis). He also is an expert in management of the complications of liver cirrhosis including portal hypertension and liver cancers.He is a fellow for the American Association for the Study of Liver Diseases, American Gastroenterology Association, and the American College of Physicians. He has served on national committees for the American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterology Association and the American Society of Transplantation.Following graduation from Temple University School of Medicine, he completed residency in internal medicine at Emory University School of Medicine, followed by a gastroenterology fellowship at the University of California, San Diego. He also completed a fellowship in advanced/transplant hepatology at both Columbia and Cornell-New York Presbyterian Hospitals. Dr. Stein is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatitis, Cirrhosis, Hepato-Pancreato-Biliary Surgery, and Liver Transplant. Dr. Stein is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine - Gastroenterology, and American Board Of Internal Medicine - Transplant Hepatology. Dr. Stein is currently accepting new patients.